S. Ausim Azizi, MD, PhD, Matthew T. Moore Chair and Professor of Investigative Neurology, Professor of Neurology, and Professor in the Center for Substance Abuse Research at the Lewis Katz School of Medicine at Temple University, spoke with KYW Newsradio about cluster headaches and the U.S. Food and Drug Administration’s recent approval of the medication Emgality for their treatment.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn More
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH